共 31 条
- [1] Nomograms in oncology: more than meets the eye [J]. LANCET ONCOLOGY, 2015, 16 (04) : E173 - E180
- [2] Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 8481 - 8490
- [3] Epidemiology of Renal Cell Carcinoma: 2022 Update [J]. EUROPEAN UROLOGY, 2022, 82 (05) : 529 - 542
- [4] Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer [J]. FRONTIERS IN ONCOLOGY, 2021, 11
- [6] Gettman MT, 2001, CANCER, V91, P354, DOI 10.1002/1097-0142(20010115)91:2<354::AID-CNCR1009>3.0.CO
- [7] 2-9
- [8] Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
- [10] Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8